Golar releases its 2023 Environmental, Social and Governance report
Golar LNG Limited (“Golar”) is pleased to announce that it has issued its 2023 Environmental, Social and Governance (“ESG”) report. […]
Futu Announces First Quarter 2024 Unaudited Financial Results
HONG KONG, May 28, 2024 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online […]
Nasdaq and FIA Tech Partner to Reduce Complexity and Increase Resiliency of Post Trade Infrastructure
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) and FIA Tech today announced they will partner to […]
WISeKey Welcomes Confederation’s Decision to Establish the “Swiss Government Cloud” by 2026
WISeKey is at the forefront of leveraging Switzerland as a central hub for data storage, including utilizing mountain facilities to […]
WISeKey International Holding Ltd Announces Agenda Items to be Approved by Shareholders at its 2024 Annual General Meeting
Zug, Switzerland, May 28, 2024 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd. […]
Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company […]
Mercer International Inc. Releases 2023 Sustainability Report
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC) — a global […]
JD.com to Hold Annual General Meeting on June 21, 2024
BEIJING, May 27, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and […]
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract; Rapid and sustained improvements in hematuria over […]
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company […]
